# Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance

> **NCT03093506** · EARLY_PHASE1 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 25 (actual)

## Conditions studied

- Human Volunteers

## Interventions

- **DRUG:** Low-dose rhEpo
- **DRUG:** Micro-dose rhEpo
- **OTHER:** Placebo Control

## Key facts

- **NCT ID:** NCT03093506
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03093506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03093506, "Effects of Micro-dose and Low-dose Recombinant Human Erythropoietin on Mitochondrial Function and Cognitive Performance". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03093506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*